Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: Effect of Vigabatrin on Brain Blood Flow and Glucose Metabolism

View source ↗

Summary

Clinical trial update examining how vigabatrin affects brain blood flow and glucose metabolism in epilepsy, including complex partial seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SABRIL (VIGABATRIN)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Epilepsy, Epilepsy, Complex Partial | Status: COMPLETED